Amazon Taps Amwell CoFounder to Lead Health Division as Top Executive Departs SP Global SPGI Dividend Appeal Highlighted as Mobility SpinOff Approaches Schwab CEO Emphasizes LongTerm Wealth Building Over Meme Coin Speculation Spotify Surges on AI Music Collaboration with Universal Music Group and Updated Outlook Oura HealthTracking Smart Ring Pioneer Files Confidentially for IPO BHP Acknowledges Decarbonisation Delays as WA Premier Urges Moral Duty on Miners CIMP Q1 2026 Earnings EPS Surpasses Estimates Amid Stable Performance BBB Foods Inc TBBB Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Quarter Repay Holdings RPAY Q1 2026 Earnings EPS Beat Drives Strong PostMarket Rally LCID Q1 2026 Earnings EPS Miss Widens Amid Revenue Visibility Challenges Ralph Lauren RL Q1 2026 Earnings EPS Beats Estimates by 66 Amid Strong Brand Execution DANA Incorporated Q1 2026 Earnings Profit Miss Weighs on Sentiment Despite Share Gain NRG Energy Sheds 17 as Shares Test Key Support Levels Alignment Healthcare ALHC Holds Steady Near Key Levels as Trading Volume Normalizes Blue Bird Corporation BLBD Slips 181 as Shares Test Key Support Levels Aegon Funding Notes AEFC Hover Near Support Amidst Modest Gain Invesco Pennsylvania Value Municipal Income Trust VPV Edges Higher Amid Steady Income Demand Oil Prices Climb as Iran Establishes New Uranium Enrichment Red Lines Washington Trust Bancorp Inc WASH Q1 2026 Earnings EPS Misses Estimates as Net Interest Margin Faces Pressure BlackRock Science and Technology Trust BST Edges Higher as Tech Sentiment Stabilizes EGBN Q1 2026 Earnings EPS Surges Past Estimates on Strong Margin and Lower Provisions FXNC Q1 2026 Earnings EPS Misses Estimates Amid Challenging Quarter Hancock Whitney Q1 2026 Earnings Slight EPS Beat Amidst Cautious Outlook CIEN Q1 2026 Earnings Solid EPS Beat Despite Revenue Caution Stock Edges Up GHC Q1 2026 Earnings EPS Surges Past Estimates by 268 Krystal Biotech KRYS Q1 2026 Earnings Strong Earnings Beat Amidst Modest Stock Decline GLMD Q4 2025 Earnings WiderThanExpected Loss as Galmed Continues Clinical Development